{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:45:20Z","timestamp":1762101920542,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T00:00:00Z","timestamp":1475452800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s12328-016-0689-9","type":"journal-article","created":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T04:22:56Z","timestamp":1475468576000},"page":"375-378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Acute exacerbation of irritable bowel syndrome prevented by prn oral triptan"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9934-7941","authenticated-orcid":false,"given":"Benjamin N. R.","family":"Cheyette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah N. R.","family":"Cheyette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,3]]},"reference":[{"key":"689_CR1","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1365-2036.2005.02463.x","volume":"21","author":"AP Hungin","year":"2005","unstructured":"Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther. 2005;21:1365\u201375.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"689_CR2","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","volume":"150","author":"F Mearin","year":"2016","unstructured":"Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393\u2013407.","journal-title":"Gastroenterology"},{"issue":"10","key":"689_CR3","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1177\/0333102415617748","volume":"36","author":"K Napthali","year":"2016","unstructured":"Napthali K, Koloski N, Talley NJ. Abdominal migraine. Cephalalgia. 2016;36(10):980\u201386.","journal-title":"Cephalalgia."},{"key":"689_CR4","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1159\/000445265","volume":"34","author":"J Tack","year":"2016","unstructured":"Tack J, Vanuytsel T, Corsetti M. Modern management of irritable bowel syndrome: more than motility. Dig Dis. 2016;34:566\u201373.","journal-title":"Dig Dis"},{"key":"689_CR5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11894-016-0517-x","volume":"18","author":"SL Shah","year":"2016","unstructured":"Shah SL, Lacy BE. Dietary interventions and irritable bowel syndrome: a review of the evidence. Curr Gastroenterol Rep. 2016;18:41.","journal-title":"Curr Gastroenterol Rep"},{"issue":"5","key":"689_CR6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jhn.12385","volume":"29","author":"YA McKenzie","year":"2016","unstructured":"McKenzie YA, Bowyer RK, Leach H, et al. British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet. 2016;29(5):549\u201375.","journal-title":"J Hum Nutr Diet."},{"key":"689_CR7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrgastro.2013.259","volume":"11","author":"HM Staudacher","year":"2014","unstructured":"Staudacher HM, Irving PM, Lomer MC, Whelan K. Mechanisms and efficacy of dietary FODMAP restriction in IBS. Nat Rev Gastroenterol Hepatol. 2014;11:256\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"689_CR8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.gastrohep.2015.07.009","volume":"39","author":"J Molina-Infante","year":"2016","unstructured":"Molina-Infante J, Serra J, Fernandez-Banares F, Mearin F. The low-FODMAP diet for irritable bowel syndrome: lights and shadows. Gastroenterol Hepatol. 2016;39:55\u201365.","journal-title":"Gastroenterol Hepatol"},{"key":"689_CR9","doi-asserted-by":"publisher","DOI":"10.5056\/jnm16001","author":"MH Farzaei","year":"2016","unstructured":"Farzaei MH, Bahramsoltani R, Abdollahi M, Rahimi R. The role of visceral hypersensitivity in irritable bowel syndrome: pharmacological targets and novel treatments. J Neurogastroenterol Motil 2016. doi: 10.5056\/jnm16001 .","journal-title":"J Neurogastroenterol Motil"},{"key":"689_CR10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cca.2009.01.028","volume":"403","author":"A Sikander","year":"2009","unstructured":"Sikander A, Rana SV, Prasad KK. Role of serotonin in gastrointestinal motility and irritable bowel syndrome. Clin Chim Acta. 2009;403:47\u201355.","journal-title":"Clin Chim Acta"},{"key":"689_CR11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11894-008-0070-3","volume":"10","author":"B Garvin","year":"2008","unstructured":"Garvin B, Wiley JW. The role of serotonin in irritable bowel syndrome: implications for management. Curr Gastroenterol Rep. 2008;10:363\u20138.","journal-title":"Curr Gastroenterol Rep"},{"key":"689_CR12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1586\/17474124.2016.1158099","volume":"10","author":"M Corsetti","year":"2016","unstructured":"Corsetti M, Whorwell P. Novel pharmacological therapies for irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2016;10:807\u201315.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"689_CR13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/1060028014528151","volume":"48","author":"AW Bundeff","year":"2014","unstructured":"Bundeff AW, Woodis CB. Selective serotonin reuptake inhibitors for the treatment of irritable bowel syndrome. Ann Pharmacother. 2014;48:777\u201384.","journal-title":"Ann Pharmacother"},{"key":"689_CR14","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/archneur.59.7.1084","volume":"59","author":"SJ Tepper","year":"2002","unstructured":"Tepper SJ, Rapoport AM, Sheftell FD. Mechanisms of action of the 5-HT1B\/1D receptor agonists. Arch Neurol. 2002;59:1084\u20138.","journal-title":"Arch Neurol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-016-0689-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-016-0689-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-016-0689-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T20:13:18Z","timestamp":1498335198000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-016-0689-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,3]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["689"],"URL":"https:\/\/doi.org\/10.1007\/s12328-016-0689-9","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2016,10,3]]}}}